top of page
Image by jacob Licht

2023 Annual Conference

Post COVID-19 Pandemic: New Frontiers and Opportunities of Antibody-Based Biologics

May 14, 2023

Boston Marriott Cambridge

Speakers

Shouye Wang

Board Member, Chinese Antibody Society

Mark Brower

Senior Director, Merck

Hong Li

Director, Merck

Zhu Chen

CSO, ProfoundBio

Zhidan Tu

Former President, Chinese Antibody Society; Senior Director, RVAC Medicines

Haibin Huang

Director of Antibody Discover, Yurogen

Tushar Garimella

Executive Director, Daiichi Sankyo

Yue Liu

CEO & Founder, Ab Studio

Paul Carter

Fellow, Genentech

Daotian Fu

Chairman of Board of Directors, Chinese Antibody Society; RemeGen

Sun Chau Siu

Head of Process Development and Customer Innovation Center, Altruist Biotechnology

Qingyan Hu

Associate Director, Regeneron

Yi Du

Senor Director, HanchorBio Inc

Mingjiu Chen

President & CEO, Biosion

Dandan Dong

Chief Business Officer, Arrivent Biopharma

Jijie Gu

CSO, WuXi Biologics

Stefano Gulla

VP, RVAC Medicines

Mitchell Ho

Board Member, Chinese Antibody Society, Director, Antibody Engineering Program, National Cancer Institute

Bo Liu

President, Chinese Antibody Society; Umabs Therapeutics

2023 conference sponsor.png
bottom of page